Abstract
Purpose
Adults with hepatocellular carcinoma (HCC) have a high symptom burden. Their quality of life (QOL) has been shown to be significantly impacted by both the disease and its treatment, adding to the high symptom burden that these patients experience. The primary aims of this paper are as follows: (1) to identify how QOL is being defined in HCC literature and (2) to identify how QOL is being measured in the HCC literature using Ferrell’s model of QOL.
Methods
A systematic review was completed of relevant studies published after 2014, using PubMed, CINHAL, and PsycInfo. Relevant studies were reviewed by 2 reviewers using PRISMA guidelines.
Results
From a total of 1312 papers obtained in the initial database search, 30 met inclusion criteria and are included in this review. From the included articles, 10% included a definition of QOL and 3% addressed the spiritual domain of QOL. Majority of study participants were in the early stage of HCC, though the majority of adults with HCC are diagnosed in the advanced stage. Only 3% of included studies included greater than 22% population of advanced stage of HCC.
Conclusion
The results of this systematic review demonstrate the need for future research into QOL in the advanced stage of QOL. It also identified gap in the literature concerning the definition of QOL in HCC and the spiritual domain of QOL in HCC.
Similar content being viewed by others
References
McGlynn, K. A., Petrick, J. L., & London, W. T. (2015). Global epidemiology of hepatocellular carcinoma: An emphasis on demographic and regional variability. Clinical Liver Disease, 19(2), 223–238.
Thomas, J. D., et al. (2011). Liver Cancer. In C. D. Blanke, C. Rödel, & M. S. Talamonti (Eds.), Gastrointestinal oncology: A practical guide (pp. 225–249). Berlin: Springer.
Bray, F., et al. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer Journal for Clinicians, 68(6), 394–424.
Jemal, A., et al. (2017). Annual report to the nation on the status of cancer, 1975–2014, featuring survival. Journal of the National Cancer Institute, 109(9), djx030.
Center for Disease Control and Prevention. (2019). Liver Cancer. Available from https://www.cdc.gov/cancer/liver/index.htm.
American Cancer Society. (2019). Cancer facts & figures 2019. [cited 2019 5/26/2019]. Available from https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2019/cancer-facts-and-figures-2019.pdf.
Mudumbi, S. K., et al. (2018). Palliative care and hospice interventions in decompensated cirrhosis and hepatocellular carcinoma: A rapid review of literature. Journal of Palliative Medicine, 21(8), 1177–1184.
Harris, R., et al. (2017). Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: A systematic review. The Lancet Gastroenterology & Hepatology, 2(4), 288–297.
Fitzmorris, P., et al. (2015). Management of hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology, 141(5), 861–876.
Ferrell, B. R., & Hassey Dow, K. (1997). Quality of life among long-term cancer survivors. Oncology, 11(4), 565–568, 571; discussion 572, 575–576.
Felce, D., & Perry, J. (1995). Quality of life: Its definition and measurement. Research in Developmental Disabilities, 16(1), 51–74.
Peplau, H. E. (1994). Quality of life: An interpersonal perspective. Nurse Science Quarterly, 7(1), 10–15.
World Health Organization. (2019). Measuring quality of life. Available from https://www.who.int/healthinfo/survey/whoqol-qualityoflife/en/.
Costa, D. S., & King, M. T. (2013). Conceptual, classification or causal: Models of health status and health-related quality of life. Expert Review of Pharmacoeconomics & Outcomes Research, 13(5), 631–640.
Ware, J. E., Jr. (1984). Methodology in behavioral and psychosocial cancer research. Conceptualizing disease impact and treatment outcomes. Cancer, 53(10 Suppl), 2316–2326.
Patrick, D. L., & Bergner, M. (1990). Measurement of health status in the 1990s. Annual Review of Public Health, 11, 165–183.
Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. Jama, 273(1), 59–65.
Read, J. L., Quinn, R. J., & Hoefer, M. A. (1987). Measuring overall health: An evaluation of three important approaches. Journal of Chronic Diseases, 40(Suppl 1), 7s–26s.
Ferrell, B. R. (1996). The quality of lives: 1,525 voices of cancer. Oncology Nursing Forum, 23(6), 909–916.
Fan, S. Y., Eiser, C., & Ho, M. C. (2010). Health-related quality of life in patients with hepatocellular carcinoma: A systematic review. Clinical Gastroenterology and Hepatology, 8(7), 559-64.e1–10.
Gandhi, S., Khubchandani, S., & Iyer, R. (2014). Quality of life and hepatocellular carcinoma. Journal of Gastrointestinal Oncology, 5(4), 296–317.
Liu, J., Mittendorf, T., & von der Schulenburg, J. M. (2010). A structured review and guide through studies on health-related quality of life in kidney cancer, hepatocellular carcinoma, and leukemia. Cancer Investigation, 28(3), 312–322.
Ouzzani, M., et al. (2016). Rayyan-a web and mobile app for systematic reviews. Systematic Review, 5(1), 210.
Pugh, R. N., et al. (1973). Transection of the oesophagus for bleeding oesophageal varices. British Journal of Surgery, 60(8), 646–649.
Bernard, M., et al. (2017). Relationship between spirituality, meaning in life, psychological distress, wish for hastened death, and their influence on quality of life in palliative care patients. Journal of Pain and Symptom Management, 54(4), 514–522.
Bovero, A., et al. (2016). Spirituality, quality of life, psychological adjustment in terminal cancer patients in hospice. European Journal of Cancer Care, 25(6), 961–969.
Wang, C. W., Chow, A. Y., & Chan, C. L. (2017). The effects of life review interventions on spiritual well-being, psychological distress, and quality of life in patients with terminal or advanced cancer: A systematic review and meta-analysis of randomized controlled trials. Palliative Medicine, 31(10), 883–894.
Znaor, A., et al. (2018). The public health challenge of liver cancer in Mongolia. The Lancet Gastroenterology & Hepatology, 3(10), 660–662.
Lemoine, M., & Thursz, M. R. (2017). Battlefield against hepatitis B infection and HCC in Africa. Journal of Hepatology, 66(3), 645–654.
Fateen, W., & Ryder, S. D. (2017). Screening for hepatocellular carcinoma: Patient selection and perspectives. Journal of Hepatocellular Carcinoma, 4, 71–79.
Scott, N. W., Fayers, P. M., Aaronson, N. K., Bottomley, A., de Graeff, A., Groenvold, M., et al. (2008). EORTC QLQ-C30 reference values. Brussels, Belgium: EORTC Quality of Life Group.
Cella, D. F., et al. (1993). The functional assessment of cancer therapy scale: Development and validation of the general measure. Journal of Clinical Oncology, 11(3), 570–579.
Phillips, R., et al. (2015). Summary scores captured changes in subjects’ QoL as measured by the multiple scales of the EORTC QLQ-C30. Journal of Clinical Epidemiology, 68(8), 895–902.
Schlachterman, A., et al. (2015). Current and future treatments for hepatocellular carcinoma. World Journal of Gastroenterology, 21(28), 8478–8491.
Bianchi, G., et al. (2003). Reduced quality of life of patients with hepatocellular carcinoma. Digestive and Liver Disease, 35(1), 46–54.
Bonnetain, F., et al. (2008). Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: Results from two French clinical trials. Quality of Life Research, 17(6), 831–843.
Chie, W. C., et al. (2017). Differences in health-related quality of life between European and Asian patients with hepatocellular carcinoma. Asia-Pacific Journal of Clinical Oncology, 13(5), e304–e311.
Diouf, M., et al. (2013). The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma. Journal of Hepatology, 58(3), 509–521.
Fan, S. Y., et al. (2013). Health-related quality of life in patients with hepatocellular carcinoma: The mediation effects of illness perceptions and coping. Psychooncology, 22(6), 1353–1360.
Gill, J., et al. (2018). Insights into the hepatocellular carcinoma patient journey: Results of the first global quality of life survey. Future Oncology, 14(17), 1701–1710.
Gmur, A., et al. (2018). FACT-Hep increases the accuracy of survival prediction in HCC patients when added to ECOG Performance Status. Liver International, 38(8), 1468–1474.
Hsu, W. C., et al. (2012). Mini-nutritional assessment predicts functional status and quality of life of patients with hepatocellular carcinoma in Taiwan. Nutrition and Cancer, 64(4), 543–549.
Jie, B., et al. (2016). Impact of disclosure of diagnosis and patient autonomy on quality of life and illness perceptions in Chinese patients with liver cancer. Psychooncology, 25(8), 927–932.
Kim, G. A., et al. (2019). A prospective evaluation of the reliability and utility of quality of life measures in patients with hepatocellular carcinoma. American Journal of Clinical Oncology, 42(7), 555–563.
Kondo, Y., et al. (2007). Health-related quality of life of chronic liver disease patients with and without hepatocellular carcinoma. Journal of Gastroenterology & Hepatology, 22(2), 197–203.
Lam, E. T., et al. (2009). Health-related quality of life of Southern Chinese with chronic hepatitis B infection. Health and Quality of Life Outcomes, 7, 52.
Li, L., et al. (2019). The association of liver function and quality of life of patients with liver cancer. BMC Gastroenterology, 19(1), 66.
Meier, A., et al. (2015). Role functioning is associated with survival in patients with hepatocellular carcinoma. Quality of Life Research, 24(7), 1669–1675.
Mikoshiba, N., et al. (2013). Depressive symptoms after treatment in hepatocellular carcinoma survivors: Prevalence, determinants, and impact on health-related quality of life. Psychooncology, 22(10), 2347–2353.
Palmieri, V. O., et al. (2015). Psychopathological profile and health-related quality of life (HRQOL) in patients with hepatocellular carcinoma (HCC) and cirrhosis. Clinical and Experimental Medicine, 15(1), 65–72.
Qiao, C. X., et al. (2012). Health-related quality of life evaluated by tumor node metastasis staging system in patients with hepatocellular carcinoma. World Journal of Gastroenterology, 18(21), 2689–2694.
Ryu, E., et al. (2010). Symptom clusters and quality of life in Korean patients with hepatocellular carcinoma. Cancer Nursing, 33(1), 3–10.
Shiraki, M., et al. (2013). Nutritional status and quality of life in current patients with liver cirrhosis as assessed in 2007–2011. Hepatology Research, 43(2), 106–112.
Steel, J. L., et al. (2006). Clinically meaningful changes in health-related quality of life in patients diagnosed with hepatobiliary carcinoma. Annals of Oncology, 17(2), 304–312.
Steel, J. L., et al. (2007). Health-related quality of life: Hepatocellular carcinoma, chronic liver disease, and the general population. Quality of Life Research Quality of Life Research, 16(2), 203–215.
Steel, J., et al. (2005). Sexual functioning in patients with hepatocellular carcinoma. Cancer, 104(10), 2234–2243.
Steel, J. L., Geller, D. A., & Carr, B. I. (2005). Proxy ratings of health related quality of life in patients with hepatocellular carcinoma. Quality of Life Research, 14(4), 1025–1033.
Sternby Eilard, M., et al. (2018). Quality of life as a prognostic factor for survival in hepatocellular carcinoma. Liver International, 38(5), 885–894.
Sun, V., et al. (2008). Symptom concerns and quality of life in hepatobiliary cancers. Oncology Nursing Forum, 35(3), E45-52.
Ueno, S., et al. (2002). Quality of life after hepatectomy in patients with hepatocellular carcinoma: Implication of change in hepatic protein synthesis. Hepato-Gastroenterology, 49(44), 492–496.
Wong, W. S., & Fielding, R. (2008). The association between patient satisfaction and quality of life in Chinese lung and liver cancer patients. Medical Care, 46(3), 293–302.
Yeo, W., et al. (2006). Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma. Annals of Oncology, 17(7), 1083–1089.
Zheng, W., et al. (2013). Survival and health-related quality of life in patients with spinal metastases originated from primary hepatocellular carcinoma. Journal of Evidence-Based Integrative Medicine, 6(2), 81–89.
Acknowledgements
A special thank you to Dr. Betty Ferrell for her review.
Funding
Funding and support provided by the ARCS foundation and the Ensign-Lewis Foundation.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Firkins, J.L., Tarter, R., Driessnack, M. et al. A closer look at quality of life in the hepatocellular carcinoma literature. Qual Life Res 30, 1525–1535 (2021). https://doi.org/10.1007/s11136-021-02789-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-021-02789-2